A risk assessment tool for resumption of research activities during the COVID-19 pandemic for field trials in low resource settings

A risk assessment tool for resumption of research activities during the COVID-19 pandemic for field trials in low resource settings

Abstract Rationale The spread of severe acute respiratory syndrome coronavirus-2 has suspended many non-COVID-19 related research activities. Where restarting research activities is permitted, investigators need to evaluate the risks and benefits of resuming data collection and adapt procedures to m...

Full description

Bibliographic Details
Main Authors: Suzanne M. Simkovich, Lisa M. Thompson, Maggie L. Clark, Kalpana Balakrishnan, Alejandra Bussalleu, William Checkley, Thomas Clasen, Victor G. Davila-Roman, Anaite Diaz-Artiga, Ephrem Dusabimana, Lisa de las Fuentes, Steven Harvey, Miles A. Kirby, Amy Lovvorn, Eric D. McCollum, Erick E. Mollinedo, Jennifer L. Peel, Ashlinn Quinn, Ghislaine Rosa, Lindsay J. Underhill, Kendra N. Williams, Bonnie N. Young, Joshua Rosenthal, HAPIN Investigators
Format: Article
Language:English
Published: BMC 2021-04-01
Series:BMC Medical Research Methodology
Subjects:
Risk assessment
Biosafety
Research
COVID-19
SARS-CoV-2
Online Access:https://doi.org/10.1186/s12874-021-01232-x

Internet

https://doi.org/10.1186/s12874-021-01232-x

Similar Items